Correlation Between Inhibrx and Ocean Biomedical

Can any of the company-specific risk be diversified away by investing in both Inhibrx and Ocean Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Ocean Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Inhibrx and Ocean Biomedical, you can compare the effects of market volatilities on Inhibrx and Ocean Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Ocean Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Ocean Biomedical.

Diversification Opportunities for Inhibrx and Ocean Biomedical

0.01

Correlation Coefficient

Inhibrx  Ocean Biomedical

Significant diversification

The 3 months correlation between Inhibrx and Ocean is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Ocean Biomedical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ocean Biomedical and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Ocean Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ocean Biomedical has no effect on the direction of Inhibrx i.e., Inhibrx and Ocean Biomedical go up and down completely randomly.

Pair Corralation between Inhibrx and Ocean Biomedical

Given the investment horizon of 90 days Inhibrx is expected to under-perform the Ocean Biomedical. But the stock apears to be less risky and, when comparing its historical volatility, Inhibrx is 6.69 times less risky than Ocean Biomedical. The stock trades about -0.02 of its potential returns per unit of risk. The Ocean Biomedical is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  9.50  in Ocean Biomedical on September 1, 2024 and sell it today you would lose (5.90) from holding Ocean Biomedical or give up 62.11% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	91.27%
Values	Daily Returns

Inhibrx  vs.  Ocean Biomedical

Inhibrx

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Inhibrx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental drivers, Inhibrx is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Ocean Biomedical

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Ocean Biomedical are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Ocean Biomedical showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Inhibrx and Ocean Biomedical

The main advantage of trading using opposite Inhibrx and Ocean Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Ocean Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ocean Biomedical will offset losses from the drop in Ocean Biomedical's long position.

The idea behind Inhibrx and Ocean Biomedical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.